Oral acetyl-L-carnitine therapy and insulin resistance.
Ruggenenti
Piero
P
van der Meer
Irene M
IM
Remuzzi
Giuseppe
G
D000108:Acetylcarnitine / Q000008:administration & dosage*; D000284:Administration, Oral; D000818:Animals; D001786:Blood Glucose / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000517:prevention & control; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy*; D019587:Dietary Supplements; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy*; D007333:Insulin Resistance / Q000502:physiology*; D008297:Male; D010865:Pilot Projects; D051381:Rats; D012680:Sensitivity and Specificity
D001786:Blood Glucose; D000108:Acetylcarnitine